Tolebrutinib Slows Disability in Non-Relapsing Secondary Progressive MS Liver toxicity may still be a concern Sep 20, 2024
Blood Markers Help Predict MS Disease Progression Patients with high NfL at disease onset may benefit from high-efficacy treatments Sep 19, 2024
Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes Analysis looks at pooled data of 17,000 MS trial participants Sep 18, 2024
Brain Training and Memory Decline; Alzheimer's Pioneer Dies; Notorious APOE4 News and commentary from the world of neurology and neuroscience Sep 17, 2024
Alzheimer's and X Chromosomes; Identifying Pediatric MOGAD; Vladimir Lenin's Death News and commentary from the world of neurology and neuroscience Sep 10, 2024
Brain Clock Disparities; How Morphine Relieves Pain; Tolebrutinib and MS Disability News and commentary from the world of neurology and neuroscience Sep 03, 2024
Intermittent Fasting Shows Promise in Multiple Sclerosis Leptin levels, immune cell profiles improved in small study Aug 21, 2024
Study Suggests No Overall Increased Risk of MS Relapse After COVID Boosters Only patients who had two or more relapses in the previous 2 years had an increased risk Aug 15, 2024
Melatonin and Alzheimer's; Napping-Parkinson's Link; An Unusual ARIA Case News and commentary from the world of neurology and neuroscience Aug 13, 2024
Vitamin D-MS Link; Nootropic Gummies Laced With Psilocybin; Forecasting Seizures News and commentary from the world of neurology and neuroscience Jul 23, 2024
Dementia and Sleep; Functional Neurologic Disorder and Long COVID; Autism-Gut Link? News and commentary from the world of neurology and neuroscience Jul 16, 2024
Your Brain on Mars; Differential Dementia Diagnosis by AI; ALS Gene Identified News and commentary from the world of neurology and neuroscience Jul 09, 2024
Alzheimer's Researcher Indicted; Predicting Parkinson's Progression; Fitness and ALS News and commentary from the world of neurology and neuroscience Jul 02, 2024
Blood Panel Predicts Parkinson's; Transgender Neurologic Care; Rare COVID Case News and commentary from the world of neurology and neuroscience Jun 25, 2024
Tetanus Shots and Parkinson's; Predicting Future Dementia; Cognition-Depression Link News and commentary from the world of neurology and neuroscience Jun 11, 2024
Duchenne Drug Fails Confirmatory Trial; COVID Brain Changes; First-Seizure Clinics News and commentary from the world of neurology and neuroscience May 28, 2024
Withdrawing Life Support; Social Mobility and Dementia; Bilateral Focused Ultrasound News and commentary from the world of neurology and neuroscience May 21, 2024
Cognitively Healthy Centenarians; Seizures and COVID Vax; New AAN Statement News and commentary from the world of neurology and neuroscience Apr 30, 2024
Closing Gender-Based Disease Disparities Starts in the Lab Women must have a seat at the table in deciding what type of research to pursue Apr 27, 2024
Alzheimer's Drug Skepticism; Safeguarding Brain Data; Benefits of Stimulating Jobs News and commentary from the world of neurology and neuroscience Apr 23, 2024
Novel Drug Made of Gold Nanocrystals Appears Safe in Multiple Sclerosis Small study suggested benefits for MS patients with chronic optic neuropathy Apr 22, 2024
Multiple Sclerosis Predicted by Autoantibody Signature Blood samples reveal signs of MS years before clinical diagnosis Apr 19, 2024
Ocrelizumab Trial Fills Research Gap for Black, Hispanic MS Patients Half of patients had no evidence of disease activity at 48 weeks Apr 18, 2024
The Dying Brain; Obesity Drugs and MS; NurOwn Tries Again News and commentary from the world of neurology and neuroscience Apr 09, 2024
Caffeine and Parkinson's; Brutally Honest Look at Dementia; Three MS Subtypes News and commentary from the world of neurology and neuroscience Apr 02, 2024
Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients Discontinuing natalizumab and fingolimod carried highest risk Mar 27, 2024
Epstein-Barr and MS; When Lewy Pathology Starts; Alzheimer's Blood Test Assessed News and commentary from the world of neurology and neuroscience Mar 19, 2024
Viagra and Alzheimer's; Migraine Consensus Statement; FDA Updates Drug Guidance News and commentary from the world of neurology and neuroscience Mar 12, 2024
Breastfeeding While Taking MS Monoclonal Antibody Drugs Appears Safe No negative effects on early infant development or health seen Mar 11, 2024
BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MS Higher tolebrutinib dose, longer treatment duration may be needed Mar 07, 2024
Evobrutinib Fails to Beat Teriflunomide in Relapsing MS No efficacy difference between the two drugs in two phase III trials Mar 06, 2024
Lucid Moments in Late Dementia; Seizure Dogs and Epilepsy; Wildfire Smoke Effects News and commentary from the world of neurology and neuroscience Mar 05, 2024
Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions Processing speed scores lower 4 years later for people with one or more baseline lesions Mar 04, 2024
Ozanimod Controls MS Disease Activity Regardless of Age Clinical, radiologic measures remained stable or improved in both younger and older patients Mar 03, 2024
Long COVID May Be Difficult to Identify in MS Tough to pinpoint what is a long-term MS symptom and what is a long COVID symptom Mar 02, 2024
Obesity Associated With Faster MS Disease Progression Increased risk of physical, psychological, cognitive decline Mar 02, 2024
Leaky Blood Vessels and Long COVID; BCG Vaccine and Alzheimer's; New CTE Subtype News and commentary from the world of neurology and neuroscience Feb 27, 2024
Herpes-Dementia Link; How COVID Affects the Brain; FDA to Decide on Duchenne Drug News and commentary from the world of neurology and neuroscience Feb 20, 2024
Highly Effective Therapies Early in Pediatric MS Linked to Reduced Relapse Risk Study supports starting kids on high-efficacy drugs, but long-term safety studies are crucial Feb 16, 2024
Novel Anti-CD40L Antibody Slows New Brain Lesions in Relapsing MS Frexalimab shows promise in phase II study Feb 14, 2024
